A blood-based multi-cancer early detection test with a positive or negative signal result, online eligibility review, clinician authorization, and results usually available in about two weeks.
- Current price
- $689
- Sample
- blood
- Turnaround
- 14 days
- Access
- Clinician Authorized, Lab visit, mobile-phlebotomy
Review status. This record is live for catalog testing, but its Test Grade and dimension scores are still awaiting editorial publication.
cancer-risk, healthy-aging
The official request page documents the total price, sample, eligibility rules, included prescription review, collection options, result format, and typical timing.
A negative result does not rule out cancer, a positive result is not a diagnosis and requires follow-up, eligibility restrictions apply, and the test is not available in New York.